Fujifilm taps drugmaker Takeda to speed stem cell treatments – Nikkei Asian Review
Nikkei Asian Review |
Fujifilm taps drugmaker Takeda to speed stem cell treatments
Nikkei Asian Review Announced Thursday, the partnership will revolve around regenerative therapies using stem–cell-derived heart muscle tissue. It marks the first collaboration between the pair and represents another move by Fujifilm to reduce its emphasis on self … |
